NCT05908253

Brief Summary

The proposed study accelerates the translational aspect of neurofeedback-based attention training using novel technologies, algorithms, and neuromarkers. The presented brain training intervention and approaches will not only be applicable to attention remedy in patients with attention deficits but also can be applied to treatment of other neurocognitive (mental) disorders such as anxiety, depression, and addiction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 1, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 18, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

December 16, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
Last Updated

May 2, 2025

Status Verified

May 1, 2025

Enrollment Period

5 months

First QC Date

March 1, 2023

Last Update Submit

May 1, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Accuracy of behavioral performance measured by push buttons in response to stimuli

    This outcome focuses on the effectiveness of closed-loop algorithms for neurofeedback-based attention training. The behavioral responses to instructed stimuli before and after closed-loop neurofeedback will be measured by push buttons and will be evaluated.

    12 months

Study Arms (3)

sham neurofeedback

SHAM COMPARATOR

Both neural activity and accuracy of behavioral responses will be evaluated before and after a closed-loop sham neurofeedback protocol.

Behavioral: sham neurofeedback

nonadaptive neurofeedback

ACTIVE COMPARATOR

Both neural activity and accuracy of behavioral responses will be evaluated before and after a closed-loop nonadaptive neurofeedback protocol. In this method, the stimuli is changed using the upcoming neural activity and an open-loop attention model of the corresponding human subject.

Behavioral: nonadaptive neurofeedback

adaptive neurofeedback

ACTIVE COMPARATOR

Both neural activity and accuracy of behavioral responses will be evaluated before and after a closed-loop adaptive neurofeedback protocol. In this method, the stimuli is changed using the upcoming neural activity and an adaptive algorithm.

Behavioral: adaptive neurofeedback

Interventions

Both neural activity and accuracy of behavioral responses will be evaluated before and after a closed-loop sham neurofeedback protocol.

sham neurofeedback

Both neural activity and accuracy of behavioral responses will be evaluated before and after a closed-loop nonadaptive neurofeedback protocol. In this method, the stimuli is changed using the upcoming neural activity and an open-loop attention model of the corresponding human subject.

nonadaptive neurofeedback

Both neural activity and accuracy of behavioral responses will be evaluated before and after a closed-loop adaptive neurofeedback protocol. In this method, the stimuli is changed using the upcoming neural activity and an adaptive algorithm.

adaptive neurofeedback

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged over 18 years
  • No prior medical record of brain damage
  • No prior diagnosis of mental issue
  • Ample physical condition to push buttons / keywords

You may not qualify if:

  • Clinical diagnosis of Alzheimer's Disease or other mental issues
  • Medical record of brain damage
  • Upper limb physical disability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Rhode Island

Kingston, Rhode Island, 02881, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 1, 2023

First Posted

June 18, 2023

Study Start

December 16, 2023

Primary Completion

April 30, 2024

Study Completion

April 30, 2024

Last Updated

May 2, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations